Literature DB >> 7541036

Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.

K Iwata1, T Seya, Y Yanagi, J M Pesando, P M Johnson, M Okabe, S Ueda, H Ariga, S Nagasawa.   

Abstract

The complement system membrane cofactor protein (MCP) CD46 serves as a C3b/C4b inactivating factor for the protection of host cells from autologous complement attack and as a receptor for measles virus (MV). MCP consists of four short consensus repeats (SCR) which are the predominant extracellular structural motif. In the present study, we determined which of the four SCR of MCP contribute to its function using Chinese hamster ovary cell clones expressing each SCR deletion mutants. The results were as follows: 1) SCR1 and SCR2 are mainly involved in MV binding and infection; 2) SCR2, SCR3, and SCR4 contribute to protect Chinese hamster ovary cells from human alternative complement pathway-mediated cytolysis; and 3) SCR2 and SCR3 are essential for protection of host cells from the classical complement pathway. These results on cell protective activity of the mutants against the human classical and the alternative complement pathways were compatible with factor I-mediated inactivation profiles of C4b and C3b, respectively, in the fluid-phase assay using solubilized mutants and factor I; the results were mostly consistent with those reported by Adams et al. (Adams, E. M., Brown, M. C., Nunge, M., Krych, M., and Atkinson, J. P. (1991) J. Immunol. 147, 3005-3011). SCR2 and SCR3 were required for C3b and C4b inactivation, and SCR4-deleted MCP showed weak cofactor activity for C4b cleavage but virtually no cofactor activity for C3b cleavage. The functional domains of MCP for the three natural ligands C3b, C4b, and MV, therefore, map to different, although partly overlapping, SCR domains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541036     DOI: 10.1074/jbc.270.25.15148

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE).

Authors:  M Kawano; T Seya; I Koni; H Mabuchi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding.

Authors:  E C Hsu; R E Dörig; F Sarangi; A Marcil; C Iorio; C D Richardson
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Identification and characterization of a silencer regulatory element in the 3'-flanking region of the murine CD46 gene.

Authors:  M Nomura; A Tsujimura; N A Begum; M Matsumoto; H Wabiko; K Toyoshima; T Seya
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

4.  The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3.

Authors:  Dominique Sirena; Benjamin Lilienfeld; Markus Eisenhut; Stefan Kälin; Karin Boucke; Roger R Beerli; Lorenz Vogt; Christiane Ruedl; Martin F Bachmann; Urs F Greber; Silvio Hemmi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  Identification of complement regulatory domains in vaccinia virus complement control protein.

Authors:  Jayati Mullick; John Bernet; Yogesh Panse; Sharanabasava Hallihosur; Akhilesh K Singh; Arvind Sahu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35.

Authors:  Christoph Fleischli; Sandra Verhaagh; Menzo Havenga; Dominique Sirena; Walter Schaffner; Roberto Cattaneo; Urs F Greber; Silvio Hemmi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 7.  Emerging roles and new functions of CD46.

Authors:  M Kathryn Liszewski; Claudia Kemper; Jeffrey D Price; John P Atkinson
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

8.  Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains.

Authors:  V Lecouturier; J Fayolle; M Caballero; J Carabaña; M L Celma; R Fernandez-Muñoz; T F Wild; R Buckland
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  Codon optimized membrane cofactor protein expression in α 1, 3 galactosyltransferase knockout pig cells improve protection against cytotoxicity of monkey serum.

Authors:  Heasun Lee; In-Sul Hwang; Bala Murali Krishna Vasamsetti; Harikrishna Reddy Rallabandi; Mi-Ryung Park; Sung-June Byun; Hyeon Yang; Sun A Ock; Hwi-Cheul Lee; Jae-Seok Woo; Seongsoo Hwang; Keon Bong Oh
Journal:  3 Biotech       Date:  2020-02-10       Impact factor: 2.406

10.  Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion.

Authors:  C J Buchholz; U Schneider; P Devaux; D Gerlier; R Cattaneo
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.